SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - N-(MERCAPTOACYL)-4-SUBSTITUTED-(S)-PROLINES

被引:71
作者
SMITH, EM [1 ]
SWISS, GF [1 ]
NEUSTADT, BR [1 ]
GOLD, EH [1 ]
SOMMER, JA [1 ]
BROWN, AD [1 ]
CHIU, PJS [1 ]
MORAN, R [1 ]
SYBERTZ, EJ [1 ]
BAUM, T [1 ]
机构
[1] SCHERING PLOUGH CORP,DEPT PHARMACOL,BLOOMFIELD,NJ 07003
关键词
D O I
10.1021/jm00399a033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:875 / 885
页数:11
相关论文
共 30 条
[1]  
ADAMS E, 1954, J BIOL CHEM, V208, P573
[2]   SYNTHESIS OF CIS AND TRANS ISOMERS OF 4-CHLORO-L-PROLINE 4-BROMO-L-PROLINE AND 4-AMINO-L-PROLINE [J].
ANDREATTA, RH ;
NAIR, V ;
ROBERTSON, AV ;
SIMPSON, WRJ .
AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (07) :1493-+
[3]   ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE [J].
BIOLLAZ, J ;
BRUNNER, HR ;
GAVRAS, I ;
WAEBER, B ;
GAVRAS, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :966-972
[4]   3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].
BIOLLAZ, J ;
BURNIER, M ;
TURINI, GA ;
BRUNNER, DB ;
PORCHET, M ;
GOMEZ, HJ ;
JONES, KH ;
FERBER, F ;
ABRAMS, WB ;
GAVRAS, H ;
BRUNNER, HR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670
[5]   ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL [J].
CHRYSANT, SG ;
BROWN, RD ;
KEM, DC ;
BROWN, JL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :741-746
[6]   EVALUATION OF A LONG-ACTING CONVERTING ENZYME-INHIBITOR (ENALAPRIL) FOR THE TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE [J].
CODY, RJ ;
COVIT, AB ;
SCHAER, GL ;
LARAGH, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (04) :1154-1159
[7]  
COWDHURY AKA, 1978, J MED CHEM, V21, P607
[8]   DESIGN OF POTENT COMPETITIVE INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - CARBOXYALKANOYL AND MERCAPTOALKANOYL AMINO-ACIDS [J].
CUSHMAN, DW ;
CHEUNG, HS ;
SABO, EF ;
ONDETTI, MA .
BIOCHEMISTRY, 1977, 16 (25) :5484-5491
[9]  
CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1673
[10]  
GOLD EH, 1984, Patent No. 4470972